Company Quick10K Filing
Zeta Acquisition I
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-28
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-03-28
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-03-31

Zeta Acquisition I Financials

ZETAI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash6,761,0003,661,0001,727,00021,225,0006,916,0003,022,0002,237,000337,00016,151,0008,026,0004,014,0003,614,0002,299,00015,599,0002,994,00022,594,0009,402,0001,258,0007,427,0001,778,00021,328,0008,885,0005,060,0001,260,0008,145,0003,252,000485,00020,185,00010,235,0004,724,000899,00022,049,0009,679,0004,412,000
Accounts Receivable
Inventory
PP&E
Assets16,151,00012,401,0004,239,0002,299,00015,599,0008,885,0005,060,0001,260,0008,145,0003,252,000485,00020,185,00010,235,0004,724,000899,00022,049,0009,679,0004,412,000
Accounts Payable2,200,0002,497,0002,952,0003,817,000175,000634,0001,850,0006,280,000175,000650,000350,000713,0008,155,00010,682,0002,402,00011,664,0003,575,0004,078,0005,600,0009,613,00011,765,0003,663,0003,750,0008,113,0002,943,0002,404,0001,500,0007,825,0001,700,0001,700,00003,295,0002,500,0002,500,000
Long-Term Debt
Liabilities126,837,000129,226,000136,580,000141,592,000161,320,000218,899,000225,795,000228,510,000244,411,000246,783,000255,090,000283,268,000280,484,000283,861,000291,538,000320,986,000319,918,000323,686,000
Stockholders' Equity-55,463,000-61,729,000-70,638,000-75,986,000-82,300,000-88,313,000-97,975,000-103,937,000-110,686,000-116,825,000-126,576,000-132,341,000-139,293,000-145,721,000-157,374,000-163,189,000-170,461,000-177,282,000-189,483,000-195,689,000-203,372,000-210,014,000-220,735,000-227,250,000-236,266,000-243,531,000-254,605,000-263,083,000-270,249,000-279,137,000-290,639,000-298,937,000-310,239,000-319,274,000
Income Statement ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A5,826,0005,359,0008,002,0004,217,0005,042,0004,728,0008,376,0004,705,0005,456,0004,475,0008,087,0004,138,0005,307,0004,765,0009,763,0003,962,0005,103,0004,648,00010,053,0003,962,0005,103,0004,340,0008,112,0003,963,0006,246,0004,354,0008,162,0005,412,0004,970,0005,599,0004,895,0007,675,0005,367,000
Tax
Net Income-6,724,000-6,266,000-8,909,000-5,348,000-6,314,000-6,013,000-9,662,000-5,962,000-6,749,000-6,139,000-9,751,000-5,765,000-6,952,000-6,428,000-11,653,000-5,815,000-7,272,000-6,821,000-12,201,000-6,206,000-7,683,000-6,642,000-10,721,000-6,515,000-9,016,000-7,265,000-11,074,000-8,478,000-7,166,000-8,888,000-8,298,000-11,302,000-9,034,000
Cash Flow ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-3,100,000-1,934,000-5,502,000-14,309,000-3,894,000-785,000-1,900,000-9,186,000-8,125,000-4,012,000-400,000-1,315,000-1,700,000-12,605,000-400,000-13,192,000-4,144,000-2,831,000-5,649,000-2,950,000-12,443,000-3,825,000-3,800,000-13,115,000-5,300,000-9,950,000-5,511,000-3,850,000-12,370,000-5,267,000
Cash Investing
Cash Financing0025,000,000000025,000,000000015,000,000020,000,0000-4,000,0009,000,000022,500,0000025,000,0000025,000,00000